Skip to main content

How much does HIV treatment Cimduo cost?

Medically reviewed by Drugs.com. Last updated on Sep 23, 2024.

Official Answer by Drugs.com

Cimduo (lamivudine and tenofovir disoproxil fumarate) is expected to be a more affordable tenofovir-based HIV product costing approximately $12,000 per year (wholesale acquisition cost).

For more information see Cimduo Prices, Coupons and Patient Assistance Programs

Cimduo contains lamivudine 300 mg and tenofovir disoproxil fumarate 300 mg and is a combination agent used with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 infection (HIV-1 infection).

According to the Fair Pricing Coalition, Cimduo's list price is expected to run 40% lower than other comparable agents currently on the market.

Cimduo, from Mylan, is predicted to compete with Truvada (emtricitabine and tenofovir disoproxil) and Descovy (emtricitabine and tenofovir alafenamide and), other HIV drugs, both from Gilead.

Unlike Truvada and Descovy, Cimduo is not approved by the FDA for use as pre-exposure prophylaxis (PrEP) to prevent HIV infection.

Read next

Does Biktarvy increase cholesterol?

Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide) can increase cholesterol levels due to the tenofovir alafenamide (TAF) component, but this does not appear to be a frequent or significant side effect. Continue reading

What drugs are contained in the HIV treatment Symtuza?

Symtuza is a four-drug combination of darunavir (DRV), a human immunodeficiency virus (HIV-1) protease inhibitor, cobicistat (COBI), a CYP3A inhibitor, and emtricitabine (FTC) and tenofovir alafenamide (TAF). Continue reading

Can Descovy be used for PrEP in HIV?

Yes. The FDA approved Descovy (emtricitabine and tenofovir alafenamide) for pre-exposure prophylaxis (PrEP) in October 2019 to help reduce the risk of HIV-1 infection. Continue reading

See also:

Related medical questions

Drug information

Related support groups